Vitalhub Corp.

TSX:VHI.TO

Medical - Healthcare Information Services

Healthcare
$6.66 +0.56%

+$0.04 today

Market cap
$421.84M
Beta
0.77
P/E (TTM)
62.1
EPS (TTM)
$0.12
52W Low $6.67High $14.64

Volume 0.23M

Average 0.41M

VHI.TO Common Stock Repurchased

Cash spent buying back the company's own shares.

Vitalhub Corp.TSX: VHI.TO

Common Stock Repurchased · Q1 FY2026 · quarter ended Mar 2026

Common stock repurchased outflow grows to CA$0

Q1 FY2026 common stock repurchased was CA$0, compared with CA$0 a year earlier. Trailing-twelve-month common stock repurchased was CA$0.

Context

  • Common stock repurchased amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Common stock repurchased increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly common stock repurchased holds near CA$0 or moves back toward the trailing-twelve-month quarterly average of CA$0.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$0— QoQ
Last fiscal yearDec 2025
CA$0— YoY
LTMMar 2026
CA$0— YoY
Common Stock Repurchased past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Common Stock Repurchased history

CAD · from the cash flow

Latest · FY2025
0 CAD
Year-over-year change
—

Common Stock Repurchased vs competitors

How VHI.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so common stock repurchased is compared through growth and share of revenue rather than absolute size.
  • Common stock repurchased amounts to 0.0% of revenue for VHI.TO, versus a peer median of 0.0%.
VHI.TO Competitors
Common Stock Repurchased for VHI.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
GUD.TOKnight Therapeutics Inc.LTM Mar 2026CA$11.24M CAD-7.9%-40.4%2.2%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$5.41M USD+314580.5%+40.2%10.6%
TSND.TOTerrAscend Corp.LTM Mar 2026$255.04K USD-42.8%—0.1%
VHI.TOVitalhub Corp.LTM Mar 2026CA$0 CAD——0.0%
KSI.TOKneat.com, Inc.LTM Mar 2026CA$0 CAD——0.0%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$0 CAD——0.0%
EDT.TOSpectral Medical Inc.LTM Mar 2026CA$0 CAD——0.0%
Peer median (excluding VHI.TO) —-7.9%-0.1%0.0%

Competitors are the stored peer set for VHI.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(1.95M)1.21M4.55M3M6.11M
Depreciation & Amortization2.68M3.87M4.98M5.96M11.08M
Deferred Income Tax(439.35K)151.46K00(3.12M)
Stock-Based Compensation1.72M1.14M1.16M2.34M2.65M
Change in Working Capital(2.14M)(997.91K)9.29M3.57M(8.27M)
Accounts Receivables(1.89M)(2.04M)2.4M(3.99M)10.14M
Inventory245.69K(504.68K)534.79K(69.97K)176.51K
Accounts Payables(662.47K)(945.73K)957.25K2.7M(9.91M)
Other Working Capital169.6K2.49M5.4M4.93M(8.68M)
Other Non-Cash Items82.43K740.39K497.09K254.53K(125.74K)
Operating Cash Flow(49.97K)6.12M20.47M15.13M8.32M
Capital Expenditures(259.61K)(295.05K)(290.11K)(883.72K)(423.15K)
Acquisitions (Net)(9.8M)(21.55M)(1.84M)(28.42M)(50.36M)
Purchases of Investments0000(160.32M)
Sales of Investments000098.77M
Other Investing Activities(457.86K)(1.54M)(2.02M)(2.09M)1.23M
Investing Cash Flow(10.06M)(21.84M)(4.15M)(31.39M)(111.11M)
Debt Repayment(372.24K)(516.17K)(399.55K)(366.37K)(595.98K)
Common Stock Issued3.54M16.3M150.73K37.51M105.18M
Common Stock Repurchased0(215.42K)(39.07K)00
Dividends Paid00000
Other Financing Activities3.54M836.22K150.73K1.94M0
Financing Cash Flow3.17M16.4M(287.89K)39.09M104.59M
Effect of Forex Changes(62.88K)381.66K(11.18K)268.5K(744.45K)
Net Change in Cash(7M)1.06M16.03M23.09M1.05M
Free Cash Flow(309.58K)5.83M20.18M14.24M7.9M

Vitalhub Corp.

TSX:VHI.TO

Intrinsic Alpha fair value

Locked

Current Price

$6.66

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.